Home / Market News / $AKSO

$AKSO news and market catalysts

The 1 most recent market catalysts affecting $AKSO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 1 high impact 1 bullish 0 bearish Biotechnology

Sep 14, 2026 Corporate Catalyst Bullish Impact 85

Reported Sunday, Ivonescimab Monotherapy Reduces Risk Of Death By 27% Versus Pembrolizumab In PD-L1-Positive Advanced NSCLC, Akeso's HARMONi-2 Study Shows

Akeso reported compelling results from its HARMONi-2 study, demonstrating that ivonescimab monotherapy reduced the risk of death by 27% compared to Merck's pembrolizumab (Keytruda)…

Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.